Logo image of MTAL

MAC COPPER LTD (MTAL) Stock Fundamental Analysis

NYSE:MTAL - New York Stock Exchange, Inc. - JE00BQBC8469 - Common Stock - Currency: USD

12.24  +0.08 (+0.66%)

After market: 12.24 0 (0%)

Fundamental Rating

3

Overall MTAL gets a fundamental rating of 3 out of 10. We evaluated MTAL against 154 industry peers in the Metals & Mining industry. Both the profitability and financial health of MTAL have multiple concerns. MTAL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MTAL has reported negative net income.
In the past year MTAL had a positive cash flow from operations.
In the past 5 years MTAL reported 4 times negative net income.
MTAL had negative operating cash flow in 4 of the past 5 years.
MTAL Yearly Net Income VS EBIT VS OCF VS FCFMTAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

MTAL has a worse Return On Assets (-5.80%) than 64.29% of its industry peers.
With a Return On Equity value of -14.71%, MTAL is not doing good in the industry: 66.23% of the companies in the same industry are doing better.
MTAL's Return On Invested Capital of 5.00% is fine compared to the rest of the industry. MTAL outperforms 64.29% of its industry peers.
Industry RankSector Rank
ROA -5.8%
ROE -14.71%
ROIC 5%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MTAL Yearly ROA, ROE, ROICMTAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40 -50

1.3 Margins

MTAL has a better Operating Margin (22.68%) than 77.92% of its industry peers.
The Gross Margin of MTAL (31.07%) is better than 72.08% of its industry peers.
Industry RankSector Rank
OM 22.68%
PM (TTM) N/A
GM 31.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MTAL Yearly Profit, Operating, Gross MarginsMTAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MTAL is destroying value.
MTAL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, MTAL has an improved debt to assets ratio.
MTAL Yearly Shares OutstandingMTAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
MTAL Yearly Total Debt VS Total AssetsMTAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of 0.90, we must say that MTAL is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, MTAL is doing worse than 77.92% of the companies in the same industry.
The Debt to FCF ratio of MTAL is 7.34, which is on the high side as it means it would take MTAL, 7.34 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.34, MTAL is in the better half of the industry, outperforming 66.23% of the companies in the same industry.
MTAL has a Debt/Equity ratio of 0.63. This is a neutral value indicating MTAL is somewhat dependend on debt financing.
MTAL has a Debt to Equity ratio of 0.63. This is amonst the worse of the industry: MTAL underperforms 81.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.34
Altman-Z 0.9
ROIC/WACC0.47
WACC10.71%
MTAL Yearly LT Debt VS Equity VS FCFMTAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.12 indicates that MTAL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.12, MTAL is doing worse than 83.12% of the companies in the same industry.
MTAL has a Quick Ratio of 1.12. This is a bad value and indicates that MTAL is not financially healthy enough and could expect problems in meeting its short term obligations.
MTAL has a worse Quick ratio (0.97) than 68.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.97
MTAL Yearly Current Assets VS Current LiabilitesMTAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

MTAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.56%, which is quite impressive.
Looking at the last year, MTAL shows a very strong growth in Revenue. The Revenue has grown by 114.30%.
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.56%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%114.3%

3.2 Future

Based on estimates for the next years, MTAL will show a very strong growth in Earnings Per Share. The EPS will grow by 60.97% on average per year.
Based on estimates for the next years, MTAL will show a quite strong growth in Revenue. The Revenue will grow by 11.76% on average per year.
EPS Next Y424.1%
EPS Next 2Y178.07%
EPS Next 3Y103.94%
EPS Next 5Y60.97%
Revenue Next Year9.76%
Revenue Next 2Y14.69%
Revenue Next 3Y12.29%
Revenue Next 5Y11.76%

3.3 Evolution

MTAL Yearly Revenue VS EstimatesMTAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
MTAL Yearly EPS VS EstimatesMTAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

MTAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 19.83, which indicates a rather expensive current valuation of MTAL.
MTAL's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.17, MTAL is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 19.83
MTAL Price Earnings VS Forward Price EarningsMTAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MTAL indicates a somewhat cheap valuation: MTAL is cheaper than 74.68% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, MTAL is valued cheaper than 80.52% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.92
EV/EBITDA 8
MTAL Per share dataMTAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

MTAL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MTAL's earnings are expected to grow with 103.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y178.07%
EPS Next 3Y103.94%

0

5. Dividend

5.1 Amount

No dividends for MTAL!.
Industry RankSector Rank
Dividend Yield N/A

MAC COPPER LTD

NYSE:MTAL (6/2/2025, 8:23:06 PM)

After market: 12.24 0 (0%)

12.24

+0.08 (+0.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-21 2025-07-21/bmo
Inst Owners41.12%
Inst Owner Change-52.53%
Ins Owners2.87%
Ins Owner ChangeN/A
Market Cap1.01B
Analysts80
Price Target14.92 (21.9%)
Short Float %2.93%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.3%
PT rev (3m)-19.31%
EPS NQ rev (1m)-32.18%
EPS NQ rev (3m)-18.05%
EPS NY rev (1m)14.87%
EPS NY rev (3m)17.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.54%
Revenue NY rev (3m)-4.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.83
P/S 2.96
P/FCF 17.92
P/OCF 8.65
P/B 1.82
P/tB 1.82
EV/EBITDA 8
EPS(TTM)-0.99
EYN/A
EPS(NY)0.62
Fwd EY5.04%
FCF(TTM)0.68
FCFY5.58%
OCF(TTM)1.42
OCFY11.57%
SpS4.13
BVpS6.74
TBVpS6.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.8%
ROE -14.71%
ROCE 6.33%
ROIC 5%
ROICexc 5.82%
ROICexgc 5.82%
OM 22.68%
PM (TTM) N/A
GM 31.07%
FCFM 16.53%
ROA(3y)-6.21%
ROA(5y)N/A
ROE(3y)-23.53%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 7.34
Debt/EBITDA 2.25
Cap/Depr 77.1%
Cap/Sales 17.73%
Interest Coverage 1.64
Cash Conversion 75.01%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.97
Altman-Z 0.9
F-Score7
WACC10.71%
ROIC/WACC0.47
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.56%
EPS Next Y424.1%
EPS Next 2Y178.07%
EPS Next 3Y103.94%
EPS Next 5Y60.97%
Revenue 1Y (TTM)114.3%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%114.3%
Revenue Next Year9.76%
Revenue Next 2Y14.69%
Revenue Next 3Y12.29%
Revenue Next 5Y11.76%
EBIT growth 1Y660.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.77%
EBIT Next 3Y50.95%
EBIT Next 5Y37.96%
FCF growth 1Y252.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1097.17%
OCF growth 3YN/A
OCF growth 5YN/A